|
09:00 – 09:20 |
Welcome by Johan Giesecke, ECDC Chief Scientist and Head of the Scientific Advice Unit |
|
09:20– 11:00 |
Session A: Measles in Europe
[1h 40 min]
Moderator: David Salisbury – Department of Health, UK
Rebecca Martin – World Health Organization Regional Office for Europe
Measles and rubella elimination in Europe – epidemiological and programmatic overview
Mircea Popa – Carol Davila University of Medicine and Pharmacy, Bucharest, Romania
Reaching the hard to reach: the Romanian experience
Günter Pfaff, Baden-Württemberg State Health Office, Germany
Reaching the hard to reach: the case of anthroposophical viewpoints |
|
11:00 – 11:20 |
Coffee break |
|
11:20 – 13:00 |
Session B: Introduction of vaccines - from decision-making to implementation and evaluation
[1h 40 min]
Moderator: Daniel Lévy-Bruhl – Institute for Public Health Surveillance (INVS), France
Graça Freitas - Directorate-General of Health, Portugal
Public sector and private market: decisions taken on MenC and PCV7 in Portugal
Roman Prymula - University hospital Hradec Kralove and Faculty of Military Health Sciences, Czech Republic
The decision making process in resource limited settings
Hans Houweling - Health Council of the Netherlands
Criteria for inclusion of vaccinations in public programmes |
|
13:00 – 14:00 |
Lunch break |
|
14:00 – 15:40 |
Session C: Pandemic vaccines and vaccination
[1h 40 min]
Moderator: Angus Nicoll - ECDC
Stefania Salmaso - National Institute of Health (ISS), Italy
Preparedness to the pandemic: the European approach to the licensure of pandemic vaccines
Anders Tegnell - National Board of Health and Welfare, Sweden
Pandemic influenza vaccination: from procurement to implementation
Cathérine Weil-Olivier – University of Paris, France
Influenza and influenza vaccination in young children and pregnant women |
|
15:40 – 16:10 |
Coffee break |
|
16:10 – 17:50 |
Session D: Vaccine safety and risk communication
[1h 40 min]
Moderator: Alberto Tozzi – Bambin Gesú Hospital Rome, Italy
Brigitte Keller-Stanislawsky - Paul-Ehrlich-Institute, Germany
Vaccine safety assessment at national level
Xavier Kurz – European Medical Agency
The EU added value for vaccine benefit-risk monitoring
Joanne Yarwood – Department of Health, UK
How to communicate the risk-benefit of vaccination to general public and health care professionals |
|
17:50 – 18:00 |
End |